OBJECTIVE: Elevated blood pressure and the Apolipoprotein ε4 allele (APOE ε4) are independent risk factors for Alzheimer's disease. We sought to determine whether the combined presence of the APOE ε4 allele and elevated blood pressure is associated with lower cognitive performance in cognitively healthy middle-aged adults. METHODS: A total of 975 participants aged 30-54 (mean age = 44.47) were genotyped for APOE. Cardiometabolic risk factors including blood pressure, lipids, and glucose were assessed and cognitive function was measured using the Trail Making Test and the Visual Reproduction and Logical Memory subtests from the Wechsler Memory Scale. RESULTS: Multivariable regression analysis showed that the association between APOE ε4 and episodic memory performance varied as a function of systolic blood pressure (SBP), such that elevated SBP was predictive of poorer episodic memory performance only in APOE ε4 carriers (β = -.092; t = -2.614; p = .009). Notably, this association was apparent at prehypertensive levels (≥130 mmHg), even after adjusting for physical activity, depression, smoking, and other cardiometabolic risk factors. CONCLUSIONS: The joint presence of APOE ε4 and elevated SBP, even at prehypertensive levels, is associated with lower cognitive performance in healthy, middle-aged adults. Results of this study suggest that the combination of APOE ε4 and elevated SBP may synergistically compromise memory function well before the appearance of clinically significant impairments. Interventions targeting blood pressure control in APOE ε4 carriers during midlife should be studied as a possible means to reduce the risk of cognitive decline in genetically susceptible samples. (c) 2015 APA, all rights reserved).
OBJECTIVE: Elevated blood pressure and the Apolipoprotein ε4 allele (APOE ε4) are independent risk factors for Alzheimer's disease. We sought to determine whether the combined presence of the APOE ε4 allele and elevated blood pressure is associated with lower cognitive performance in cognitively healthy middle-aged adults. METHODS: A total of 975 participants aged 30-54 (mean age = 44.47) were genotyped for APOE. Cardiometabolic risk factors including blood pressure, lipids, and glucose were assessed and cognitive function was measured using the Trail Making Test and the Visual Reproduction and Logical Memory subtests from the Wechsler Memory Scale. RESULTS: Multivariable regression analysis showed that the association between APOE ε4 and episodic memory performance varied as a function of systolic blood pressure (SBP), such that elevated SBP was predictive of poorer episodic memory performance only in APOE ε4 carriers (β = -.092; t = -2.614; p = .009). Notably, this association was apparent at prehypertensive levels (≥130 mmHg), even after adjusting for physical activity, depression, smoking, and other cardiometabolic risk factors. CONCLUSIONS: The joint presence of APOE ε4 and elevated SBP, even at prehypertensive levels, is associated with lower cognitive performance in healthy, middle-aged adults. Results of this study suggest that the combination of APOE ε4 and elevated SBP may synergistically compromise memory function well before the appearance of clinically significant impairments. Interventions targeting blood pressure control in APOE ε4 carriers during midlife should be studied as a possible means to reduce the risk of cognitive decline in genetically susceptible samples. (c) 2015 APA, all rights reserved).
Authors: David Zade; Alexa Beiser; Regina McGlinchey; Rhoda Au; Sudha Seshadri; Carole Palumbo; Philip A Wolf; Charles Decarli; William Milberg Journal: J Stroke Cerebrovasc Dis Date: 2010-05-14 Impact factor: 2.136
Authors: M Kivipelto; E L Helkala; M P Laakso; T Hänninen; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen Journal: BMJ Date: 2001-06-16
Authors: A Collie; P Maruff; R Shafiq-Antonacci; M Smith; M Hallup; P R Schofield; C L Masters; J Currie Journal: Neurology Date: 2001-06-12 Impact factor: 9.910
Authors: Matthew F Muldoon; Christopher M Ryan; Lei Sheu; Jeffrey K Yao; Sarah M Conklin; Stephen B Manuck Journal: J Nutr Date: 2010-02-24 Impact factor: 4.798
Authors: Lenore J Launer; Timothy Hughes; Binbing Yu; Kamal Masaki; Helen Petrovitch; G Webster Ross; Lon R White Journal: Hypertension Date: 2010-04-19 Impact factor: 10.190
Authors: Robert S Wilson; Julie A Schneider; Lisa L Barnes; Laurel A Beckett; Neelum T Aggarwal; Elizabeth J Cochran; Elizabeth Berry-Kravis; Julie Bach; Jacob H Fox; Denis A Evans; David A Bennett Journal: Arch Neurol Date: 2002-07
Authors: Elizabeth C Leritz; David H Salat; William P Milberg; Victoria J Williams; Caroline E Chapman; Laura J Grande; James L Rudolph; David M Schnyer; Colleen E Barber; Lewis A Lipsitz; Regina E McGlinchey Journal: Neuropsychology Date: 2010-03 Impact factor: 3.295
Authors: Mark James Rawle; Daniel Davis; Rebecca Bendayan; Andrew Wong; Diana Kuh; Marcus Richards Journal: Transl Psychiatry Date: 2018-01-10 Impact factor: 6.222
Authors: Paul Denver; Heather D'Adamo; Shuxin Hu; Xiaohong Zuo; Cansheng Zhu; Chihiro Okuma; Peter Kim; Daniel Castro; Mychica R Jones; Carmen Leal; Marisa Mekkittikul; Elham Ghadishah; Bruce Teter; Harry V Vinters; Gregory Michael Cole; Sally A Frautschy Journal: Front Physiol Date: 2019-10-24 Impact factor: 4.566
Authors: Richard N Henson; Sana Suri; Ethan Knights; James B Rowe; Rogier A Kievit; Donald M Lyall; Dennis Chan; Else Eising; Simon E Fisher Journal: Brain Neurosci Adv Date: 2020-10-07